These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 10364346
21. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2. Wang K, Goodman KN, Li DY, Raffeld M, Chavez M, Cohen JI. J Virol; 2016 Jan 01; 90(1):562-74. PubMed ID: 26559846 [Abstract] [Full Text] [Related]
22. Anterograde transport of herpes simplex virus proteins in axons of peripheral human fetal neurons: an immunoelectron microscopy study. Holland DJ, Miranda-Saksena M, Boadle RA, Armati P, Cunningham AL. J Virol; 1999 Oct 01; 73(10):8503-11. PubMed ID: 10482603 [Abstract] [Full Text] [Related]
25. Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons. Miranda-Saksena M, Armati P, Boadle RA, Holland DJ, Cunningham AL. J Virol; 2000 Feb 01; 74(4):1827-39. PubMed ID: 10644356 [Abstract] [Full Text] [Related]
26. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera. Luo Y, Xiong D, Li HH, Qiu SP, Lin CL, Chen Q, Huang CH, Yuan Q, Zhang J, Xia NS. Virol J; 2016 Mar 18; 13():44. PubMed ID: 26987753 [Abstract] [Full Text] [Related]
28. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. Dingwell KS, Brunetti CR, Hendricks RL, Tang Q, Tang M, Rainbow AJ, Johnson DC. J Virol; 1994 Feb 18; 68(2):834-45. PubMed ID: 8289387 [Abstract] [Full Text] [Related]
29. Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons. Saksena MM, Wakisaka H, Tijono B, Boadle RA, Rixon F, Takahashi H, Cunningham AL. J Virol; 2006 Apr 18; 80(7):3592-606. PubMed ID: 16537627 [Abstract] [Full Text] [Related]
30. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. Nicola AV, Ponce de Leon M, Xu R, Hou W, Whitbeck JC, Krummenacher C, Montgomery RI, Spear PG, Eisenberg RJ, Cohen GH. J Virol; 1998 May 18; 72(5):3595-601. PubMed ID: 9557640 [Abstract] [Full Text] [Related]
32. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir. Hensel MT, Marshall JD, Dorwart MR, Heeke DS, Rao E, Tummala P, Yu L, Cohen GH, Eisenberg RJ, Sloan DD. J Virol; 2017 May 01; 91(9):. PubMed ID: 28228587 [Abstract] [Full Text] [Related]
33. Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. Navarro D, Paz P, Pereira L. Virology; 1992 Jan 01; 186(1):99-112. PubMed ID: 1370130 [Abstract] [Full Text] [Related]
34. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. Dingwell KS, Doering LC, Johnson DC. J Virol; 1995 Nov 01; 69(11):7087-98. PubMed ID: 7474128 [Abstract] [Full Text] [Related]
35. A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease. Bauer D, Alt M, Dirks M, Buch A, Heilingloh CS, Dittmer U, Giebel B, Görgens A, Palapys V, Kasper M, Eis-Hübinger AM, Sodeik B, Heiligenhaus A, Roggendorf M, Krawczyk A. Front Microbiol; 2017 Nov 01; 8():2115. PubMed ID: 29163407 [Abstract] [Full Text] [Related]
36. Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. York IA, Johnson DC. J Infect Dis; 1993 Nov 01; 168(5):1127-32. PubMed ID: 8228345 [Abstract] [Full Text] [Related]
37. Modulation of herpes simplex virus (HSV) infection of cultured neuronal cells by nerve growth factor and antibody to HSV. Clements GB, Kennedy PG. Brain; 1989 Oct 01; 112 ( Pt 5)():1277-94. PubMed ID: 2804613 [Abstract] [Full Text] [Related]
38. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Ritchie MH, Oakes JE, Lausch RN. Invest Ophthalmol Vis Sci; 1993 Jul 01; 34(8):2460-8. PubMed ID: 8392037 [Abstract] [Full Text] [Related]
39. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL. J Virol; 1994 Apr 01; 68(4):2118-26. PubMed ID: 8138996 [Abstract] [Full Text] [Related]
40. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus. Okubo Y, Uchida H, Wakata A, Suzuki T, Shibata T, Ikeda H, Yamaguchi M, Cohen JB, Glorioso JC, Tagaya M, Hamada H, Tahara H. J Virol; 2016 Dec 15; 90(24):11096-11105. PubMed ID: 27707922 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]